Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 6Phase 2/3 2Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Fatigue 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Melatonin × Clear all
NCT00925899 2017-04-20

Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer

Bispebjerg Hospital

Phase 2/3 Completed
72 enrolled 11 charts

Fatigue, Neoplasms

NCT01706627 2012-10-15

MIRCIT

Khon Kaen University

Phase 2/3 Completed
175 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡